Acumen Hypotension Prediction Index (HPI) Feature Software vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by FibriCheck

AI Verdict

Tool A focuses on the proactive prediction and management of hypotensive events within acute care settings, integrating with advanced monitoring platforms to aid clinicians. In contrast, Tool B is a smartphone-based application designed for remote patient monitoring and detection of arrhythmias, primarily for chronic heart rhythm conditions. While both leverage AI in cardiology, their distinct target conditions, deployment models, and primary users position them as adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your clinical environment demands real-time, proactive management of hemodynamic instability in critically ill or surgical patients. This tool is ideal for anesthesiologists and critical care teams needing to predict and prevent hypotensive events up to 15 minutes before they occur, leveraging advanced machine learning integrated into existing monitoring platforms. It is best suited for acute care settings where immediate intervention based on predictive analytics can significantly improve patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose FibriCheck if…

Choose FibriCheck if you require a convenient, patient-centric solution for remote heart rhythm monitoring and arrhythmia detection using just a smartphone. This app is perfect for cardiologists and primary care providers looking to empower patients to self-monitor for conditions like Atrial Fibrillation, offering immediate results and a professional portal for oversight. It excels in long-term, non-invasive monitoring outside of acute care settings, facilitating early detection and ongoing management of cardiac arrhythmias.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software FibriCheck
Pricing Unknown Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment Unknown Cloud-based (private cloud).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck leverages ubiquitous smartphone technology for patient-friendly heart rhythm monitoring, making it highly accessible and intuitive for end-users. Its cloud-based app deployment offers broad reach and ease of adoption for individual patients and smaller clinics, contrasting with Acumen HPI's integration into a specialized hospital platform.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI offers predictive capabilities for acute hypotensive events in critical care, with demonstrated reductions in the incidence, duration, and severity of intraoperative hypotension. This direct impact on preventing severe complications in high-acuity settings represents significant and immediate clinical value.

Pricing & Value

FibriCheck

FibriCheck provides transparent and publicly available pricing models for both end-users and healthcare providers, allowing for clear cost-benefit analysis. In contrast, Acumen HPI's pricing is opaque, requiring direct vendor contact, which hinders immediate value assessment and comparison.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, indicating a robust solution designed for complex hospital environments. Its explicit Business Associate Agreement (BAA) and deployment by a major medical device company underscore its readiness for enterprise-level adoption and compliance.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' utilizing machine learning for predictive analysis of blood pressure waveforms to anticipate hypotension up to 15 minutes in advance. This proactive prediction of acute, critical events in a clinical setting represents a significant innovation in patient safety and hemodynamic management.

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

As a complex medical device integrated into a hospital monitoring platform by a large, established company like Edwards Lifesciences (now part of BD), Acumen HPI benefits from extensive professional support, clinical education, and comprehensive technical documentation for its target audience of clinicians and hospital staff. FibriCheck also offers support and user manuals, but the depth of enterprise-grade support for a critical care system is typically more robust.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software FibriCheck
Name Acumen Hypotension Prediction Index (HPI) Feature Software FibriCheck
Company Edwards Lifesciences Qompium nv
Description A predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes. A medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.
Key Functionality Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen for impending hypotensive events, Relationship View screen providing insights into preload, afterload, and contractility, Machine learning algorithms for predictive analysis of blood pressure waveforms, Predicts hypotension up to 15 minutes before an event. Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis, Detection of Atrial Fibrillation (AFib) and other arrhythmias, Immediate and actionable results, Ability to log blood pressure and weight, Customizable monitoring rules for healthcare providers.
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and FibriCheck.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates into acute care workflows (OR, ICU, ER) via the HemoSphere platform, providing real-time predictive alerts for hypotension up to 15 minutes in advance, aiding proactive hemodynamic management in high-acuity patients. FibriCheck fits into cardiology, family medicine, and internal medicine workflows by enabling remote, patient-initiated heart rhythm monitoring for arrhythmia detection and management, empowering patients while providing healthcare professionals with a portal to monitor results and customize rules for ongoing surveillance.
Acumen HPI, as an integrated feature of the Edwards Lifesciences HemoSphere platform, would likely offer robust data export capabilities to EHRs, though specific integration depth beyond the platform is not explicitly detailed. FibriCheck offers API-based integration into existing EHRs, RPM platforms, and population health systems through its healthcare professional portal, allowing for data exchange and streamlined patient data management.
Acumen HPI software demonstrated high accuracy in predicting hypotension, with an internal validation showing 89% specificity and 90% sensitivity 10 minutes before an event, and a reduction in incidence, duration, and severity of intraoperative hypotension. FibriCheck demonstrated high overall performance for AF detection with 98.5% accuracy, 96.3% sensitivity, and 99.3% specificity in a multicenter study, though sensitivity was reduced in individuals with darker skin tones and higher BMIs, which was mitigated by technician verification.
For Acumen HPI, clinicians require training to interpret the HPI parameter, Smart Alerts, Smart Trend, and Relationship View screens, with Edwards Lifesciences providing clinical education resources. For FibriCheck, the mobile application is designed for patient ease of use, and a healthcare professional portal is available, supported by resources like the FibriCheck Academy for clinical knowledge and educational content.
Acumen HPI deployment involves integration into existing or new HemoSphere advanced monitoring platforms across acute care settings, requiring coordination with hospital IT and clinical engineering, with time-to-value realized as clinicians adopt predictive insights to proactively manage hypotension. FibriCheck, being a cloud-based digital application, facilitates rapid deployment across multiple clinics through licensing agreements and onboarding, with quick time-to-value in expanding remote arrhythmia detection and management programs.
The provided information for Acumen HPI does not explicitly detail specific audit trail features, but the HemoSphere platform, which integrates HPI, would typically include such functionalities for monitoring data, alerts, and user interactions. FibriCheck's healthcare professional portal would likely offer audit trail features to track patient measurements, generated alerts, and any reviews or actions taken by healthcare providers, ensuring accountability and a record of monitoring activities.
AI Tool Finder
AI-powered search. Results may not be comprehensive.